Under the treatment of Chl-T, TRPM2 on the cell membrane of melanoma can also increase the activation of two other potassium channels (BK channel and KCa3.1) on the stimulating membrane by mediating intracellular Ca2+, which are involved in the progression of melanoma [22]. The gene discussed is KCNMA1; the disease is melanoma.